IHT Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

IHT Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,368	Closed	-$27K	–	954
2022 Q3	$27K	Hold	17,368	–	–	﹤0.01%	854
2022 Q2	$35K	Hold	17,368	–	–	﹤0.01%	715
2022 Q1	$40K	Sell	17,368 -125	-0.7%	-$390	﹤0.01%	746
2021 Q4	$81K	Hold	17,493	–	–	0.01%	782
2021 Q3	$133K	Sell	17,493 -1,550	-8%	-$13.1K	0.01%	769
2021 Q2	$185K	Hold	19,043	–	–	0.01%	882
2021 Q1	$157K	Sell	19,043 -14,212	-43%	-$150K	0.01%	791
2020 Q4	$227K	Buy	33,255 +1,570	+5%	+$12.6K	0.02%	649
2020 Q3	$353K	Buy	31,685 +50	+0.2%	+$458	0.04%	434
2020 Q2	$199K	Buy	+31,635	New	+$121K	0.03%	530
2018 Q2	–	Sell	-423	Closed	-$2K	–	1468
2018 Q1	$2K	Buy	+423	New	+$3.01K	﹤0.01%	1544

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

IHT Wealth Management's SRNE Position: Q4 2022 in Review

IHT Wealth Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 17,368 shares — an estimated $27K sold.

IHT Wealth Management first reported a position in SRNE in Q1 2018 and held it in 11 quarters. The position peaked at $353K in Q3 2020. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

IHT Wealth Management reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
IHT Wealth Management sold 17,368 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $27K.
IHT Wealth Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2018 and held it in 11 quarters.
IHT Wealth Management's Sorrento Therapeutics, Inc. position peaked at $353K in Q3 2020.
221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on IHT Wealth Management's 13F filing for Q4 2022, filed 15 Feb 2023.